Figure 3 illustrates the seasonal variation in insulin, adiponectin, leptin, and HOMA-IR levels in healthy individuals and those with metabolic syndrome (MS) across the high- and low-PM2.5-exposure seasons. This evidence concerns the gene INS and myeloid sarcoma.